The Ledger

MCK

Mckesson CorporationHealth Careinsider_universe

Last close $1,102.81Nov 12, 2026

Day +2.39%

Currently held

Agent 20 — SIR Price/Volumelong
1 sh @ $995.28 · stop $939.47
+$108.16 unrealized

Everything we've seen

❖Nov 13, 6:02 PMnewsvia finnhub
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
Amgen trades at a lower forward P/E than Vertex, but Vertex's near-zero debt and cystic fibrosis dominance make the trade-off harder to call.
?Nov 13, 3:25 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.0% intraday with no attributable headline catalyst, suggesting either institutional flow or sector rotation. However, with only 20 minutes remaining until the forced close at 3:45 PM ET, there is minimal time for further meaningful upside to materialize toward the +3% profit target. The macro context shows T10Y2Y at 2.0σ below its 24-month trend, which benefits defensives — MCK as a healthcare distributor fits that profile and could be receiving defensive rotation flows, which is modestly supportive. However, the extreme time constraint dominates: 20 minutes is insufficient for a 1%+ additional move in a name like MCK unless there is aggressive late-session accumulation already underway. With no news to sustain narrative momentum and end-of-day profit-taking risk elevated after a 2% run, the probability of meaningful continuation is below the 0.5 threshold. The risk/reward of entering now with a tight stop and only 20 minutes of runway does not justify the trade.
!Nov 13, 3:25 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.0% intraday with no attributable headline catalyst, suggesting either institutional flow or sector rotation. However, with only 20 minutes remaining until the forced close at 3:45 PM ET, there is minimal time for further meaningful upside to materialize toward the +3% profit target. The macro context shows T10Y2Y at 2.0σ below its 24-month trend, which benefits defensives — MCK as a healthcare distributor fits that profile and could be receiving defensive rotation flows, which is modestly supportive. However, the extreme time constraint dominates: 20 minutes is insufficient for a 1%+ additional move in a name like MCK unless there is aggressive late-session accumulation already underway. With no news to sustain narrative momentum and end-of-day profit-taking risk elevated after a 2% run, the probability of meaningful continuation is below the 0.5 threshold. The risk/reward of entering now with a tight stop and only 20 minutes of runway does not justify the trade.
?Nov 13, 1:51 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.66% today, a moderate but meaningful move suggesting real institutional flow. No headlines are present to explain the move, but absence of news is not disqualifying — this could be sector rotation into defensives/healthcare distribution names, which is consistent with the macro backdrop: T10Y2Y at 2σ below trend suggests a flattening/defensive environment that can benefit healthcare distributors like MCK. The macro context (bear-flattening signal) is modestly supportive for defensive sectors. With 115 minutes remaining, there is adequate time for continuation into the close. However, at only 1.66%, the move is below the 2% threshold where momentum evidence becomes strongly compelling, and without a clear catalyst the setup is ordinary rather than high-conviction. No reversal signals are evident. Overall, this is a borderline-to-modest continuation setup — no strong reason to fade, modest reason to expect drift higher into close, warranting a probability just above the 0.5 threshold.
!Nov 13, 1:51 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.66% today, a moderate but meaningful move suggesting real institutional flow. No headlines are present to explain the move, but absence of news is not disqualifying — this could be sector rotation into defensives/healthcare distribution names, which is consistent with the macro backdrop: T10Y2Y at 2σ below trend suggests a flattening/defensive environment that can benefit healthcare distributors like MCK. The macro context (bear-flattening signal) is modestly supportive for defensive sectors. With 115 minutes remaining, there is adequate time for continuation into the close. However, at only 1.66%, the move is below the 2% threshold where momentum evidence becomes strongly compelling, and without a clear catalyst the setup is ordinary rather than high-conviction. No reversal signals are evident. Overall, this is a borderline-to-modest continuation setup — no strong reason to fade, modest reason to expect drift higher into close, warranting a probability just above the 0.5 threshold.
?Nov 13, 10:35 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.50% today, a moderate but meaningful move suggesting real institutional flow. There are no headlines to attribute this to, which is common — the move itself is evidence of conviction. MCK is a healthcare/distribution defensive name, which is relevant given the macro context: T10Y2Y at 2.0σ below trend suggests a flattening/mildly inverted curve environment that tends to favor defensives. This is a mild tailwind for MCK continuing higher. However, at 1.50% the move is below the 2% threshold where momentum evidence becomes truly compelling, and with 310 minutes remaining (roughly 5+ hours, suggesting this is quite early in the session), there is ample time for both continuation and reversal. No reversal signals are evident — no fade pattern described, no adverse news. With no strong reason to fade and a macro backdrop modestly supportive of defensive names, the base case is mild continuation, but conviction is not high enough to push above 0.65.
!Nov 13, 10:35 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.50% today, a moderate but meaningful move suggesting real institutional flow. There are no headlines to attribute this to, which is common — the move itself is evidence of conviction. MCK is a healthcare/distribution defensive name, which is relevant given the macro context: T10Y2Y at 2.0σ below trend suggests a flattening/mildly inverted curve environment that tends to favor defensives. This is a mild tailwind for MCK continuing higher. However, at 1.50% the move is below the 2% threshold where momentum evidence becomes truly compelling, and with 310 minutes remaining (roughly 5+ hours, suggesting this is quite early in the session), there is ample time for both continuation and reversal. No reversal signals are evident — no fade pattern described, no adverse news. With no strong reason to fade and a macro backdrop modestly supportive of defensive names, the base case is mild continuation, but conviction is not high enough to push above 0.65.
❖Nov 11, 3:21 PMnewsvia finnhub
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
❖Nov 11, 11:49 AMnewsvia finnhub
Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs
McKesson Corporation (MCK) shares up over 235% since May 2022 thanks to institutional support.
❖Nov 11, 8:00 AMnewsvia finnhub
Rod O'Reilly Joins Sirona Medical's Board of Directors
Sirona Medical, Inc. ("Sirona"), the market leader in cloud-native radiology software, today announced that Rod O'Reilly has joined its Board of Directors. He brings more than 25 years of executive leadership in healthcare technology and medical imaging, both as a business leader and board member.
❖Nov 11, 6:04 AMnewsvia finnhub
What iShares MSCI USA Min Vol Factor ETF (USMV) Bought: Microsoft Leads on Nov. 9
The fund added $168.9 million in gross purchases, increasing 172 positions and trimming none, with Microsoft the largest buy at $2.9 million.
❖Nov 10, 2:42 PMnewsvia finnhub
3 Reasons Why Growth Investors Shouldn't Overlook McKesson (MCK)
McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
❖Nov 10, 8:11 AMnewsvia finnhub
Can Cardinal Health Stock Repeat Its Last Five Years?
For questions about this article or underlying research, email help@trefis.com.
❖Nov 10, 7:44 AMnewsvia finnhub
JP Morgan Maintains Overweight on McKesson, Raises Price Target to $1255
JP Morgan analyst Lisa Gill maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $1042 to $1255.
❖Nov 9, 3:56 PMnewsvia finnhub
McKesson Consensus Price Target Raised 10% to $1,157.23
❖Nov 9, 11:36 AMnewsvia finnhub
Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment
Market Updates News Commentary - Health care stocks moved higher with the broader market on Monday morning. As of 9:58 a.m. ET, the State Street Health Care Select Sector SPDR ETF was up 0.88% at $186.42, while the S&P 500 was up 1.70% at 7,501.96. Medicare Open Enrollment is underway, and over the past week companies in pharmaceuticals, biotechnology, health insurance, medical devices and drug distribution have reported quarterly results or regulatory news. Active Companies from around the mark
❖Nov 9, 8:00 AMnewsvia finnhub
Gabelli Releases Agenda for 8th Annual Healthcare Symposium
PALM BEACH, Florida, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Gabelli today released the agenda for its 8th Annual Healthcare Symposium to be held this Friday, November 13 in conjunction with Columbia Business School at the Paley Center for Media in New York. The symposium will bring together leading companies and organizations from across the healthcare ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals. This symposium features three panel discussions with seni
❖Nov 8, 3:37 PMnewsvia finnhub
5 insightful analyst questions from McKesson’s Q3 CY2026 earnings call
McKesson’s results in the third quarter reflected continued momentum in its core pharmaceutical distribution and specialty services. Management highlighted strong performance from North American Pharmaceutical and Oncology & Multispecialty, driven by higher prescription volume—including GLP-1 medications—and provider platform growth. CEO Brian Tyler underscored the strategic value of recent acquisitions, noting, “Our acquisition of Precision Medicine Group adds global clinical research and comme
❖Nov 8, 3:12 AMnewsvia finnhub
McKesson (MCK) Plans Medical Surgical Spin Off With $1.25 Billion Backing
McKesson (NYSE:MCK) plans to spin off its Medical-Surgical Solutions segment into a separate company, according to a recent announcement. Apollo affiliated investors agreed to invest US$1.25b in the new Medical-Surgical Solutions entity as part of the separation plan. The transaction is structured as a spin off, which would separate McKesson's medical-surgical distribution activities from its remaining operations. This planned spin off of Medical-Surgical Solutions backed by Apollo's...
❖Nov 7, 11:14 AMnewsvia finnhub
McKesson Q2 Earnings Call Highlights
McKesson (NYSE:MCK) raised its fiscal 2027 adjusted earnings outlook after reporting higher second-quarter revenue and profit, supported by prescription volumes, specialty distribution and demand for medication access services. The company now expects adjusted earnings of $45.60 to $46.40 per dilut
❖Nov 6, 6:26 PMnewsvia finnhub
Is McKesson Stock Increasing Your Market Risk?
For questions about this article or underlying research, email help@trefis.com.
❖Nov 6, 11:00 AMnewsvia finnhub
McKesson (MCK) Upgraded to Buy: Here's What You Should Know
McKesson (MCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
❖Nov 6, 8:15 AMnewsvia finnhub
McKesson Corporation (MCK) Hit a 52 Week High, Can the Run Continue?
McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
❖Nov 5, 3:58 PMnewsvia finnhub
UBS Maintains Buy on McKesson, Raises Price Target to $1250
UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $1200 to $1250.
❖Nov 5, 1:50 PMnewsvia finnhub
McKesson Corp.: Normalized Earnings Suggest Attractive Valuation
Aristotle Capital details its investment thesis for McKesson in Q3 2026 commentary. Read more for full analytical insights.
✓Nov 5, 1:06 PMdecisionacted
Agent 7 — Day Trader — decide: buy
MCK is up 1.90% on a strong Q2 earnings beat with raised guidance — a classic post-earnings momentum setup with fundamental justification. The catalyst is clear: specialty segment growth drove the beat and management raised the outlook, which typically prompts analyst upgrades and institutional accumulation throughout the session. With 160 minutes remaining, there is ample time for continuation buying from portfolio managers who need to add or rebalance after the guidance raise. The macro backdrop (elevated DFF) is modestly relevant to MCK as a healthcare distributor — not a direct headwind, as rising rates do not materially compress MCK's business model the way they would banks. The 1.90% move is meaningful but not exhausted; it leaves room to push toward the +3% target before the forced close. No reversal signals noted — the move appears sustained rather than a gap-and-fade pattern. Probability set at 0.72 reflecting strong fundamental catalyst, adequate time, and typical post-earnings drift behavior for a large-cap that has beaten and raised.
❖Nov 5, 12:27 PMnewsvia finnhub
MCK Q2 Earnings Call Highlights Raised Outlook and Specialty Growth
McKesson raises its fiscal 2027 earnings outlook after strong Q2 results, fueled by specialty drug demand, operating gains and higher-margin healthcare expansion.
❖Nov 5, 12:15 PMnewsvia finnhub
Drug Wholesalers Go Three-For-Three In Earnings Beats, But Only Two Stocks Pop
Drug distributors went three-for-three, with Cardinal Health putting up the last fall-quarter beat on Thursday, following the examples set by McKesson and Cencora.
❖Nov 5, 11:39 AMnewsvia finnhub
What Just Happened To Medline Stock?
For questions about this article or underlying research, email help@trefis.com.
❖Nov 5, 11:31 AMnewsvia finnhub
TD Cowen Maintains Buy on McKesson, Raises Price Target to $1200
TD Cowen analyst Charles Rhyee maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $1006 to $1200.
❖Nov 5, 11:25 AMnewsvia finnhub
Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?
Amgen's growth engine and Pfizer's value appeal pull in opposite directions, and the valuation gap between them is wider than many expect.
❖Nov 5, 10:53 AMnewsvia finnhub
Leerink Partners Maintains Outperform on McKesson, Raises Price Target to $1200
Leerink Partners analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $1070 to $1200.
❖Nov 5, 10:36 AMnewsvia finnhub
RBC Capital Maintains Sector Perform on McKesson, Raises Price Target to $965
RBC Capital analyst Ryan Halsted maintains McKesson (NYSE:MCK) with a Sector Perform and raises the price target from $845 to $965.
❖Nov 5, 8:30 AMnewsvia finnhub
McKesson Corporation Q2 2027 Earnings Call Summary
Moby summary of McKesson Corporation's Q2 2027 earnings call
❖Nov 5, 8:00 AMnewsvia finnhub
MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
McKesson's Q2 fiscal 2027 earnings beat estimates on specialty growth and higher prescription volumes, prompting raised guidance despite an after-hours stock dip.
❖Nov 5, 6:50 AMnewsvia finnhub
Bristol Gate U.S. Equity Q3 2026 Portfolio Review
Microsoft was the largest contributor, with its shares up 37.8% for the quarter. KLA and Applied Materials were the largest detractors, falling 35.3% and 29.2%.
❖Nov 5, 5:22 AMnewsvia finnhub
Evercore ISI Group Maintains Outperform on McKesson, Raises Price Target to $1200
Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $1000 to $1200.
❖Nov 5, 2:15 AMnewsvia finnhub
McKesson Corp (MCK) (Q2 2027) Earnings Call Highlights: Raised Guidance, GLP-1 Momentum, and ...
McKesson Corp (MCK) lifted fiscal 2027 adjusted EPS guidance to $45.60--$46.40 on 8% revenue growth to $111 billion, strong GLP-1 distribution, and the Precision Medicine Group acquisition.
❖Nov 4, 10:18 PMnewsvia finnhub
McKesson Corporation Reports Fiscal 2027 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
▢Nov 4, 7:00 PMjournal
Agent 7 — Day Trader opened long 2 @ $1,089.74
▣Nov 4, 7:00 PMjournaltime_stop
Agent 7 — Day Trader closed long 2 @ $1,075.36 (-$28.76)
EOD forced close — day trader never carries overnight
❖Nov 4, 6:35 PMnewsvia finnhub
McKesson (NYSE:MCK) Posts Q2 EPS Beat, In-Line Revenue, and Raises Outlook
McKesson beat Q2 EPS estimates, matched revenue, and raised FY adjusted EPS guidance despite a flat after-hours reaction following a strong recent rally.
❖Nov 4, 6:35 PMnewsvia finnhub
McKesson’s (NYSE:MCK) Q3 CY2026 adjusted EPS top estimates
Healthcare distributor and services company McKesson (NYSE:MCK) beat Wall Street’s revenue expectations in calendar Q3 2026 (fiscal Q2 2027), with revenue up 7.6% year on year to $111 billion. Its non-GAAP profit of $11.68 per share was 8.6% above analysts’ consensus estimates.
❖Nov 4, 5:00 PMnewsvia finnhub
Here's What Key Metrics Tell Us About McKesson (MCK) Q2 Earnings
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
❖Nov 4, 4:50 PMnewsvia finnhub
McKesson (MCK) Beats Q2 Earnings and Revenue Estimates
McKesson (MCK) delivered earnings and revenue surprises of +9.26% and +0.77%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
❖Nov 4, 4:28 PMnewsvia finnhub
The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know
McKesson stock was flat late Wednesday, though the drug wholesaler topped fiscal second-quarter views and hiked its earnings guide.
❖Nov 4, 4:19 PMnewsvia finnhub
Medline Soars 18% on Q3 Earnings Beat, Raised Sales Outlook and $1 Billion Buyback
Key TakeawaysMedline shares jumped 18% after a third-quarter beat, a raised sales outlook and a $1 billion buyback. Organic sales grew 10.
❖Nov 4, 4:19 PMnewsvia finnhub
McKesson: Fiscal Q2 Earnings Snapshot
IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Wednesday reported fiscal second-quarter net income of $1.
❖Nov 4, 4:10 PMnewsvia finnhub
McKesson Reports Fiscal 2027 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
IRVING, Texas, November 04, 2026--McKesson Corporation (NYSE: MCK) has released its fiscal 2027 second quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
❖Nov 4, 3:24 PMnewsvia finnhub
McKesson Corporation (MCK) Q2 2027 Earnings Call Transcript
McKesson Corporation (MCK) Q2 2027 Earnings Call November 4, 2026 4:30 PM ESTCompany ParticipantsPaula Adkison - Senior Vice President of Corporate Finance,...
❖Nov 4, 2:34 PMnewsvia finnhub
UPDATE: McKesson Raises FY2027 Adj EPS Guidance from $44.20-$45.00 to $45.60-$46.40 vs $44.71 Est; Raises FY2027 Sales Guidance from $423.601B-$439.739B to $427.636B-$443.773B vs $432.063B Est
McKesson (NYSE:MCK) raises FY2027 Adj EPS guidance from $44.20-$45.00 to $45.60-$46.40 vs $44.71 analyst estimate. Raises FY2027 sales outlook from $423.601 billion-$439.739 billion to $427.636 billion-$443.773 billion
❖Nov 4, 1:35 PMnewsvia finnhub
McKesson Q2 2027 Earnings Call Transcript
McKesson (NYSE:MCK) reported second-quarter financial results on Wednesday. The transcript from the company’s second-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
❖Nov 4, 12:08 PMnewsvia finnhub
McKesson Raises FY2027 Adj EPS Guidance from $44.20-$45.00 to $45.60-$46.40 vs $44.71 Est
McKesson (NYSE:MCK) raises FY2027 Adj EPS guidance from $44.20-$45.00 to $45.60-$46.40 vs $44.71 analyst estimate..
❖Nov 4, 12:08 PMnewsvia finnhub
McKesson Q2 Adj. EPS $11.68 Beats $10.70 Estimate, Sales $110.957B Beat $109.875B Estimate
McKesson (NYSE:MCK) reported quarterly earnings of $11.68 per share which beat the analyst consensus estimate of $10.70 by 9.16 percent. This is a 18.46 percent increase over earnings of $9.86 per share from the same
❖Nov 4, 12:01 PMnewsvia finnhub
McKesson Corporation 2027 Q2 - Results - Earnings Call Presentation
2026-11-04. The following slide deck was published by McKesson Corporation in conjunction with their 2027 Q2 earnings call.
❖Nov 4, 8:31 AMnewsvia finnhub
Dow Rallies 2.9%, Oil Sinks 7% After Midterms: Stock Market Today
Democrats' sweep of Congress lifted hyperscalers and retailers, sank oil and data-center builders, and pulled yields lower.
❖Nov 4, 7:11 AMnewsvia finnhub
Why McKesson (MCK) Is Back In The Spotlight
McKesson (MCK) is back in focus after its board affirmed a regular quarterly dividend of $0.94 per share, payable on January 4, 2027, to shareholders of record on December 1, 2026. At around $999.62 per share, McKesson has seen firm momentum recently, with a 30-day share price return of 10.79% and a 90-day move of 13.95%. A 5-year total shareholder return of 367.39% points to a powerful long-run compounding story. Scan how McKesson compares with other potential momentum and quality...
❖Nov 4, 7:00 AMnewsvia finnhub
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026
BANNOCKBURN, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights (year-over-year comparisons unless otherwise noted) Net revenue of $1,493.5 million, up 4.1%GAAP net income of $57.4 million, up 10.8%GAAP diluted earnings
❖Nov 3, 11:31 AMnewsvia finnhub
ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test
ARM Holdings headlines Wednesday’s reports, with investors looking for evidence that AI-related demand can support the chip designer after a sharp stock pullback. McDonald’s, Novo Nordisk, Uber Technologies, CVS Health
✓Oct 30, 6:21 PMdecisionacted
Agent 20 — SIR Price/Volume — buy
[cluster_break_up] From 2026-10-21 through 2026-10-29, MCK pulled back from its $1,030.12 peak and consolidated in a tight price band roughly between $960 and $981 on diminishing volume (508K–764K/day), forming a classic low-volume cluster. On 2026-10-30, price broke decisively back above $995 on volume of 1.9M — a z-score of 13.29 versus the trailing 20-day ADV of 686K — representing nearly 2.8× the prior cluster's average daily turnover and the single largest-volume session in the observed window. This explosive re-expansion of volume on an up-day, exiting a well-defined consolidation zone, is the textbook SIR cluster_break_up signal: fresh demand absorbing the float left by the six-day pullback and re-establishing upward price momentum toward prior highs near $1,010–$1,030. Risks: The bullish read would be invalidated if today's 1.9M volume bar proves to be a one-session anomaly (e.g., index rebalance or options expiration flow) with no follow-through — specifically, if MCK fails to hold above the $980–$985 cluster floor and rolls over on expanding down-day volume in the next 2–3 sessions. Additionally, the elevated mortgage rate environment (7.24%, +2.3σ) poses broader macro headwinds for risk assets; while Health Care is not directly rate-sensitive, a broad equity de-rating driven by tightening financial conditions could overwhelm the stock-specific PV signal.
?Oct 15, 10:40 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.16% today with no attributable headline, suggesting institutional flow or sector rotation drove the move. With 305 minutes remaining (essentially a full afternoon session), there is ample time for continuation. However, the macro context is mildly unfavorable: 5-year forward inflation expectations (T5YIFR) are running 1.6σ above trend, which pressures rate-sensitive and growth-premium sectors broadly — though MCK as a healthcare distributor is relatively defensive and less rate-sensitive than financials or utilities, limiting macro headwind. The absence of news cuts both ways: no catalyst to sustain momentum, but also no catalyst to reverse it. The move is meaningful at 2.16% but not extreme enough to signal an exhaustion blow-off. With a bounded risk profile (-1.5% stop, +3% target, forced flatten at 3:45 PM), the asymmetry favors taking the trade at a modest continuation read. No reversal signals or fade pattern evident from available data. Assigning slight lean toward continuation given strong intraday move and defensive sector characteristics buffering macro headwind.
!Oct 15, 10:40 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.16% today with no attributable headline, suggesting institutional flow or sector rotation drove the move. With 305 minutes remaining (essentially a full afternoon session), there is ample time for continuation. However, the macro context is mildly unfavorable: 5-year forward inflation expectations (T5YIFR) are running 1.6σ above trend, which pressures rate-sensitive and growth-premium sectors broadly — though MCK as a healthcare distributor is relatively defensive and less rate-sensitive than financials or utilities, limiting macro headwind. The absence of news cuts both ways: no catalyst to sustain momentum, but also no catalyst to reverse it. The move is meaningful at 2.16% but not extreme enough to signal an exhaustion blow-off. With a bounded risk profile (-1.5% stop, +3% target, forced flatten at 3:45 PM), the asymmetry favors taking the trade at a modest continuation read. No reversal signals or fade pattern evident from available data. Assigning slight lean toward continuation given strong intraday move and defensive sector characteristics buffering macro headwind.
?Oct 1, 11:56 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 4.25% today — a significant move reflecting real institutional flow. No headlines are available to explain the catalyst, but absence of news is not disqualifying; this magnitude of move implies size conviction. With 229 minutes remaining (~3.8 hours), there is ample time for continuation into the close. The macro context shows the 5Y5Y forward inflation rate elevated at 2.0σ above trend, which is modestly negative for rate-sensitive sectors broadly, but MCK as a healthcare distributor has limited direct rate sensitivity and would not typically be a primary victim of that dynamic. The elevated inflation forward rate could actually support defensive healthcare names. No reversal signals are noted — no fade described, no abnormal volume flags. The setup is ordinary momentum with no strong countervailing reason to expect a fade, putting this in the 0.5–0.65 band. Assigning 0.54 to reflect mild continuation bias: the move is large enough to attract profit-taking risk, macro headwinds are minor but present, and no fresh catalyst sustains the narrative into close.
!Oct 1, 11:56 AMsignalseverity 0.04
Agent 7 — Day Trader — day_trade_skipped
MCK is up 4.25% today — a significant move reflecting real institutional flow. No headlines are available to explain the catalyst, but absence of news is not disqualifying; this magnitude of move implies size conviction. With 229 minutes remaining (~3.8 hours), there is ample time for continuation into the close. The macro context shows the 5Y5Y forward inflation rate elevated at 2.0σ above trend, which is modestly negative for rate-sensitive sectors broadly, but MCK as a healthcare distributor has limited direct rate sensitivity and would not typically be a primary victim of that dynamic. The elevated inflation forward rate could actually support defensive healthcare names. No reversal signals are noted — no fade described, no abnormal volume flags. The setup is ordinary momentum with no strong countervailing reason to expect a fade, putting this in the 0.5–0.65 band. Assigning 0.54 to reflect mild continuation bias: the move is large enough to attract profit-taking risk, macro headwinds are minor but present, and no fresh catalyst sustains the narrative into close.
?Oct 1, 10:10 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 4.60% today with no attributable headline, suggesting large institutional flow — likely a catalyst such as an earnings pre-announcement, contract win, or sector rotation that hasn't hit public feeds yet. The move is meaningful and represents real conviction. However, several factors temper enthusiasm: (1) At 335 minutes remaining this is very early in the session, which ordinarily would be bullish for continuation, but a 4.60% move this early also raises mean-reversion risk as latecomers sell into strength. (2) The macro backdrop shows 5Y5Y forward inflation (T5YIFR) running 2.0σ above trend, suggesting elevated rate expectations — MCK as a healthcare distributor is not classically rate-sensitive, so macro headwind is modest but present. (3) No news confirmation means the move could be driven by a single large block trade or algo sweep that may not sustain. (4) The +3% profit target from current levels would require the stock to reach ~$919, a stretch given it has already moved 4.6% without news. On balance, momentum-following logic and the bounded risk structure (tight -1.5% stop, forced EOD flatten) support a mild continuation bias, but confidence is low — this reads as ordinary momentum without strong corroborating signals.
!Oct 1, 10:10 AMsignalseverity 0.05
Agent 7 — Day Trader — day_trade_skipped
MCK is up 4.60% today with no attributable headline, suggesting large institutional flow — likely a catalyst such as an earnings pre-announcement, contract win, or sector rotation that hasn't hit public feeds yet. The move is meaningful and represents real conviction. However, several factors temper enthusiasm: (1) At 335 minutes remaining this is very early in the session, which ordinarily would be bullish for continuation, but a 4.60% move this early also raises mean-reversion risk as latecomers sell into strength. (2) The macro backdrop shows 5Y5Y forward inflation (T5YIFR) running 2.0σ above trend, suggesting elevated rate expectations — MCK as a healthcare distributor is not classically rate-sensitive, so macro headwind is modest but present. (3) No news confirmation means the move could be driven by a single large block trade or algo sweep that may not sustain. (4) The +3% profit target from current levels would require the stock to reach ~$919, a stretch given it has already moved 4.6% without news. On balance, momentum-following logic and the bounded risk structure (tight -1.5% stop, forced EOD flatten) support a mild continuation bias, but confidence is low — this reads as ordinary momentum without strong corroborating signals.
?Sep 30, 9:45 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is down 1.55% today, which is a moderate but not outsized move. No headlines are available to explain the selling, so this could be sector rotation, quiet distribution, or macro-driven pressure. The macro context shows 5-year forward inflation expectations (T5YIFR) running 2.0σ above trend — elevated inflation expectations can pressure rate-sensitive names broadly, though MCK as a healthcare distributor is not a primary rate-sensitive name. The lack of news means no catalyst-driven momentum to lean on. With 360 minutes remaining (full day essentially), there is ample time for either continuation or reversal. The move magnitude (1.55%) is real but below the 2-5% threshold that would signal strong conviction flow. No reversal pattern is evident either. On balance, the setup is borderline — slight lean toward continuation given the full day remaining and absence of any reversal signal, but conviction is low. Assigning minimum continuation threshold.
!Sep 30, 9:45 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is down 1.55% today, which is a moderate but not outsized move. No headlines are available to explain the selling, so this could be sector rotation, quiet distribution, or macro-driven pressure. The macro context shows 5-year forward inflation expectations (T5YIFR) running 2.0σ above trend — elevated inflation expectations can pressure rate-sensitive names broadly, though MCK as a healthcare distributor is not a primary rate-sensitive name. The lack of news means no catalyst-driven momentum to lean on. With 360 minutes remaining (full day essentially), there is ample time for either continuation or reversal. The move magnitude (1.55%) is real but below the 2-5% threshold that would signal strong conviction flow. No reversal pattern is evident either. On balance, the setup is borderline — slight lean toward continuation given the full day remaining and absence of any reversal signal, but conviction is low. Assigning minimum continuation threshold.
?Sep 15, 9:45 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is down 2.22% with 360 minutes remaining — a meaningful intraday move with substantial time left in the session. No headlines are available to explain the move, which is consistent with institutional repositioning or sector rotation rather than a news-driven spike that might mean-revert quickly. The macro context shows the 5-year forward inflation rate (T5YIFR) printing 1.8σ above its 24-month trend, signaling elevated inflation expectations. MCK (McKesson) is a healthcare distributor — not a classic rate-sensitive name — so the macro factor is not a strong direct headwind or tailwind here, limiting its explanatory power. With no catalyst to reverse the selling and a clean 2%+ downside move already established, momentum slightly favors continuation into the close. However, the absence of a clear fundamental driver, no sector-specific pressure identified, and MCK's defensive characteristics (which tend to attract buy-the-dip interest) temper conviction. This reads as an ordinary momentum continuation setup — no strong reversal signal present, no thin volume warning, ample time remaining — warranting a modest continuation probability just above the threshold.
!Sep 15, 9:45 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is down 2.22% with 360 minutes remaining — a meaningful intraday move with substantial time left in the session. No headlines are available to explain the move, which is consistent with institutional repositioning or sector rotation rather than a news-driven spike that might mean-revert quickly. The macro context shows the 5-year forward inflation rate (T5YIFR) printing 1.8σ above its 24-month trend, signaling elevated inflation expectations. MCK (McKesson) is a healthcare distributor — not a classic rate-sensitive name — so the macro factor is not a strong direct headwind or tailwind here, limiting its explanatory power. With no catalyst to reverse the selling and a clean 2%+ downside move already established, momentum slightly favors continuation into the close. However, the absence of a clear fundamental driver, no sector-specific pressure identified, and MCK's defensive characteristics (which tend to attract buy-the-dip interest) temper conviction. This reads as an ordinary momentum continuation setup — no strong reversal signal present, no thin volume warning, ample time remaining — warranting a modest continuation probability just above the threshold.
?Sep 2, 2:40 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.82% today with 65 minutes remaining — a meaningful move but not outsized for this name. No headlines explain the move, suggesting institutional flow rather than a news catalyst, which can sustain or reverse unpredictably. The macro context shows T5YIFR elevated at 1.7σ above trend, indicating rate-sensitive sectors face a mild headwind; MCK as a healthcare distributor is not highly rate-sensitive, so this is a modest negative but not disqualifying. With only 65 minutes to close, there is limited runway to hit the +3% target from current levels (would require an additional ~1.18% gain). The move is real and represents conviction, but the combination of no catalyst, mildly unfavorable rate environment for risk assets broadly, and limited time remaining keeps this a borderline call. No reversal signals are evident, so momentum bias tilts marginally toward continuation. Probability set just above the 0.5 threshold reflecting genuine uncertainty without a clear fade signal.
!Sep 2, 2:40 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.82% today with 65 minutes remaining — a meaningful move but not outsized for this name. No headlines explain the move, suggesting institutional flow rather than a news catalyst, which can sustain or reverse unpredictably. The macro context shows T5YIFR elevated at 1.7σ above trend, indicating rate-sensitive sectors face a mild headwind; MCK as a healthcare distributor is not highly rate-sensitive, so this is a modest negative but not disqualifying. With only 65 minutes to close, there is limited runway to hit the +3% target from current levels (would require an additional ~1.18% gain). The move is real and represents conviction, but the combination of no catalyst, mildly unfavorable rate environment for risk assets broadly, and limited time remaining keeps this a borderline call. No reversal signals are evident, so momentum bias tilts marginally toward continuation. Probability set just above the 0.5 threshold reflecting genuine uncertainty without a clear fade signal.
?Sep 2, 10:40 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.55% today with no attributable headline, suggesting quiet institutional accumulation or sector rotation rather than a news-driven spike that might fade. The move is modest (sub-2%), not extended enough to trigger mean-reversion concern. With 305 minutes remaining there is ample time for continuation into the close. The macro context shows 5-year forward inflation expectations elevated at 1.7σ above trend, which modestly pressures rate-sensitive sectors, but MCK (healthcare distribution/managed care-adjacent) has low direct rate sensitivity and is not a primary beneficiary or victim of that dynamic. No reversal pattern or news catalyst to fade is evident. The setup is ordinary positive momentum with no strong reason to reverse — slight lean toward continuation but no high-conviction signal.
!Sep 2, 10:40 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.55% today with no attributable headline, suggesting quiet institutional accumulation or sector rotation rather than a news-driven spike that might fade. The move is modest (sub-2%), not extended enough to trigger mean-reversion concern. With 305 minutes remaining there is ample time for continuation into the close. The macro context shows 5-year forward inflation expectations elevated at 1.7σ above trend, which modestly pressures rate-sensitive sectors, but MCK (healthcare distribution/managed care-adjacent) has low direct rate sensitivity and is not a primary beneficiary or victim of that dynamic. No reversal pattern or news catalyst to fade is evident. The setup is ordinary positive momentum with no strong reason to reverse — slight lean toward continuation but no high-conviction signal.
?Sep 1, 12:45 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.36% with 180 minutes remaining — a meaningful intraday move with real flow behind it and ample time to extend. No headlines are present, which is neutral rather than negative; large moves in MCK (a healthcare distribution mega-cap) often reflect institutional rebalancing or sector rotation rather than single news catalysts. The macro context (elevated 2Y yields at 2σ above trend) is modestly unfavorable for rate-sensitive sectors but MCK is a defensive healthcare name with relatively low duration sensitivity and tends to be insulated from rate pressure. No reversal signals are evident — the move is directional from open without a described fade off highs. With 3 hours remaining, there is sufficient session time for continuation. However, the absence of a clear catalyst limits conviction above the baseline, and elevated short-term rates could weigh on broader risk appetite into the close. Assigning a moderate continuation probability consistent with ordinary momentum in the absence of a strong counter-thesis.
!Sep 1, 12:45 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.36% with 180 minutes remaining — a meaningful intraday move with real flow behind it and ample time to extend. No headlines are present, which is neutral rather than negative; large moves in MCK (a healthcare distribution mega-cap) often reflect institutional rebalancing or sector rotation rather than single news catalysts. The macro context (elevated 2Y yields at 2σ above trend) is modestly unfavorable for rate-sensitive sectors but MCK is a defensive healthcare name with relatively low duration sensitivity and tends to be insulated from rate pressure. No reversal signals are evident — the move is directional from open without a described fade off highs. With 3 hours remaining, there is sufficient session time for continuation. However, the absence of a clear catalyst limits conviction above the baseline, and elevated short-term rates could weigh on broader risk appetite into the close. Assigning a moderate continuation probability consistent with ordinary momentum in the absence of a strong counter-thesis.
?Sep 1, 10:40 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.28% today with no headline catalyst identified, suggesting this is flow/positioning-driven rather than news-driven. At 305 minutes remaining (roughly 5+ hours), there is ample time for continuation. MCK is a defensive healthcare distributor — largely insensitive to the elevated 2yr yield (4.34, +2σ) macro context that primarily pressures banks and long-duration tech. The absence of a news driver is not disqualifying per methodology; the move itself represents meaningful conviction from size participants. However, without a clear catalyst or confirmation of sustained volume, and given the move is already 2.28% off the prior close (approaching the lower bound of the 2-5% 'meaningful' range), there is some risk of a midday fade or consolidation. No reversal signals are evident. Net assessment: modest upside continuation bias with no strong reason to expect fade, but no high-conviction setup either. Probability set at 0.54 — slightly above threshold reflecting ordinary momentum in a macro-insensitive sector with time remaining.
!Sep 1, 10:40 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.28% today with no headline catalyst identified, suggesting this is flow/positioning-driven rather than news-driven. At 305 minutes remaining (roughly 5+ hours), there is ample time for continuation. MCK is a defensive healthcare distributor — largely insensitive to the elevated 2yr yield (4.34, +2σ) macro context that primarily pressures banks and long-duration tech. The absence of a news driver is not disqualifying per methodology; the move itself represents meaningful conviction from size participants. However, without a clear catalyst or confirmation of sustained volume, and given the move is already 2.28% off the prior close (approaching the lower bound of the 2-5% 'meaningful' range), there is some risk of a midday fade or consolidation. No reversal signals are evident. Net assessment: modest upside continuation bias with no strong reason to expect fade, but no high-conviction setup either. Probability set at 0.54 — slightly above threshold reflecting ordinary momentum in a macro-insensitive sector with time remaining.
?Aug 25, 2:50 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.82% today with no attributed headline, suggesting institutional flow or a sector rotation into defensive/healthcare names. The move is meaningful in magnitude and likely driven by real conviction. However, with only 55 minutes remaining until the forced close, there is limited runway for the +3% profit target to be reached from current levels (would require another ~0.18% from here, which is achievable but tight). The macro context shows 5Y forward inflation expectations elevated at 1.8σ above trend — rate-sensitive sectors face some headwind, but MCK as a healthcare distributor is not a primary rate-sensitive name and may be benefiting from a defensive rotation in a higher-inflation regime. No news to catalysol a reversal, and no fade signal is evident. With no reversal pattern flagged and the move already near the profit target threshold, this is a borderline continuation setup. Probability slightly above 0.5 given modest time remaining and no adverse catalysts, but not a high-conviction setup warranting 0.7+.
!Aug 25, 2:50 PMsignalseverity 0.03
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.82% today with no attributed headline, suggesting institutional flow or a sector rotation into defensive/healthcare names. The move is meaningful in magnitude and likely driven by real conviction. However, with only 55 minutes remaining until the forced close, there is limited runway for the +3% profit target to be reached from current levels (would require another ~0.18% from here, which is achievable but tight). The macro context shows 5Y forward inflation expectations elevated at 1.8σ above trend — rate-sensitive sectors face some headwind, but MCK as a healthcare distributor is not a primary rate-sensitive name and may be benefiting from a defensive rotation in a higher-inflation regime. No news to catalysol a reversal, and no fade signal is evident. With no reversal pattern flagged and the move already near the profit target threshold, this is a borderline continuation setup. Probability slightly above 0.5 given modest time remaining and no adverse catalysts, but not a high-conviction setup warranting 0.7+.
?Aug 25, 1:10 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.82% today with ~155 minutes remaining — a moderate move with reasonable time left. No news headlines are available to explain the move, but per guidance, absence of news does not disqualify continuation. The macro context (5Y5Y forward inflation 1.8σ above trend) is modestly negative for rate-sensitive sectors, but MCK as a healthcare distribution company has relatively low direct rate sensitivity compared to REITs or utilities. The 1.82% move is meaningful but sits at the lower bound of the 'significant flow' range, suggesting some conviction but not a blowout. With no reversal signals, no fade pattern mentioned, and ample time remaining, the base case is modest continuation. However, without a clear catalyst or strong sector tailwind, and with slightly elevated inflation expectations that could weigh on risk appetite broadly into the close, this is a borderline read. Assigning a slim continuation edge above 0.5 in the absence of countervailing evidence.
!Aug 25, 1:10 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.82% today with ~155 minutes remaining — a moderate move with reasonable time left. No news headlines are available to explain the move, but per guidance, absence of news does not disqualify continuation. The macro context (5Y5Y forward inflation 1.8σ above trend) is modestly negative for rate-sensitive sectors, but MCK as a healthcare distribution company has relatively low direct rate sensitivity compared to REITs or utilities. The 1.82% move is meaningful but sits at the lower bound of the 'significant flow' range, suggesting some conviction but not a blowout. With no reversal signals, no fade pattern mentioned, and ample time remaining, the base case is modest continuation. However, without a clear catalyst or strong sector tailwind, and with slightly elevated inflation expectations that could weigh on risk appetite broadly into the close, this is a borderline read. Assigning a slim continuation edge above 0.5 in the absence of countervailing evidence.
?Aug 24, 11:46 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.60% with ~239 minutes remaining, a moderate move without a clear news catalyst. This is below the 2-5% threshold where momentum is most compelling, but still represents meaningful upside flow. No headlines suggest a reversal catalyst. The macro context shows 5Y5Y inflation expectations elevated (~1.6σ above trend), which is modestly unfavorable for rate-sensitive sectors broadly, but MCK as a healthcare distributor is not particularly rate-sensitive and should not be directly impaired. Absence of news is not disqualifying per the framework. With nearly 4 hours remaining, there is ample time for continuation. The move is not extreme enough to flag exhaustion or overextension. No reversal pattern or volume concern is evident from available data. Overall this reads as ordinary momentum with no strong reason to fade — probability set just above the 0.5 threshold.
!Aug 24, 11:46 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.60% with ~239 minutes remaining, a moderate move without a clear news catalyst. This is below the 2-5% threshold where momentum is most compelling, but still represents meaningful upside flow. No headlines suggest a reversal catalyst. The macro context shows 5Y5Y inflation expectations elevated (~1.6σ above trend), which is modestly unfavorable for rate-sensitive sectors broadly, but MCK as a healthcare distributor is not particularly rate-sensitive and should not be directly impaired. Absence of news is not disqualifying per the framework. With nearly 4 hours remaining, there is ample time for continuation. The move is not extreme enough to flag exhaustion or overextension. No reversal pattern or volume concern is evident from available data. Overall this reads as ordinary momentum with no strong reason to fade — probability set just above the 0.5 threshold.
?Aug 10, 6:04 PMdecisionconsidered
Agent 20 — SIR Price/Volume — skip
[distribution] The 20-day PV path tells a clear distributional story. The sharp up-day on 2026-07-28 ($889.50, 1.6M — the single largest volume session in the window) marked the price apex, but that high-volume surge was immediately followed by five consecutive down-days (Jul 29–Aug 3) on sustained above-average volume (838K–1.4M vs. 998K ADV), pulling price from $888.56 all the way back to $827.14 — a classic "buy the news, sell into strength" distribution signature. The most recent three sessions (Aug 5–Aug 7) show a brief reflexive bounce to $877.23 on 1.1M, immediately reversed on Aug 6 (−0.67%, 1.6M) and Aug 7 (−0.21%, 1.6M): net negative price movement on the heaviest volume of the sub-period, confirming sellers are re-emerging at the highs. The overall 20-day path drifts down-and-right from the Jul-28 peak, with down-day volume consistently meeting or exceeding up-day volume since that climax bar. Risks: A decisive reclaim of the $889–$890 level on volume materially above 1.6M (the current supply ceiling) would invalidate the distributional read and reopen the bullish case. Additionally, the macro context (5Y inflation expectations 1.6σ below trend) primarily favors Gold/Energy/TIPS rather than Health Care, so an unexpected sector rotation into defensive Health Care names could lift MCK independently of its PV structure.
?Aug 5, 10:06 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up ~2.93% intraday, which represents meaningful institutional flow and conviction. No news headlines are present, but per guidance, absence of news is not disqualifying — large moves often occur on institutional rebalancing, sector rotation, or positioning ahead of known catalysts. The macro context (5Y breakeven inflation at 1.9σ below trend) is modestly favorable for defensive/healthcare names like MCK, as low inflation expectations tend to support growth-oriented multiples and reduce cost-pressure fears for healthcare distributors. With 340 minutes remaining (session just past midpoint), there is ample time for continuation. However, the lack of a clear catalyst and no volume signal to assess creates uncertainty. The move is meaningful but not extreme (under 3%), and without a news driver or clear sector tailwind specific to MCK, this reads as ordinary momentum. Positioning modestly long with the expectation that intraday momentum and the supportive macro backdrop (low inflation = less margin pressure for distributors) allow partial continuation into the close, but not a high-conviction setup.
!Aug 5, 10:06 AMsignalseverity 0.03
Agent 7 — Day Trader — day_trade_skipped
MCK is up ~2.93% intraday, which represents meaningful institutional flow and conviction. No news headlines are present, but per guidance, absence of news is not disqualifying — large moves often occur on institutional rebalancing, sector rotation, or positioning ahead of known catalysts. The macro context (5Y breakeven inflation at 1.9σ below trend) is modestly favorable for defensive/healthcare names like MCK, as low inflation expectations tend to support growth-oriented multiples and reduce cost-pressure fears for healthcare distributors. With 340 minutes remaining (session just past midpoint), there is ample time for continuation. However, the lack of a clear catalyst and no volume signal to assess creates uncertainty. The move is meaningful but not extreme (under 3%), and without a news driver or clear sector tailwind specific to MCK, this reads as ordinary momentum. Positioning modestly long with the expectation that intraday momentum and the supportive macro backdrop (low inflation = less margin pressure for distributors) allow partial continuation into the close, but not a high-conviction setup.
?Jul 30, 10:41 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is down 2.17% with no attributable headline, suggesting institutional selling or sector rotation rather than a news-driven panic that might quickly reverse. The macro context (5Y inflation expectations 1.5σ below trend) is modestly deflationary, which is neutral-to-slightly-negative for healthcare distributors like MCK as it implies softer pricing power broadly, though MCK is not a primary sector reactor to TIPS/inflation signals. With 305 minutes remaining there is ample time for continuation, but also ample time for a mean-reversion bounce. The absence of news cuts both ways — no catalyst to drive further aggressive selling, but also no catalyst to spark a reversal. The move is meaningful (>2%) and likely reflects real institutional flow, which statistically tends to persist intraday more often than not. No reversal pattern is evident from the data provided. Overall, slight lean toward continuation down given the magnitude and real-flow inference, but conviction is modest — probability just above the 0.5 threshold.
!Jul 30, 10:41 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is down 2.17% with no attributable headline, suggesting institutional selling or sector rotation rather than a news-driven panic that might quickly reverse. The macro context (5Y inflation expectations 1.5σ below trend) is modestly deflationary, which is neutral-to-slightly-negative for healthcare distributors like MCK as it implies softer pricing power broadly, though MCK is not a primary sector reactor to TIPS/inflation signals. With 305 minutes remaining there is ample time for continuation, but also ample time for a mean-reversion bounce. The absence of news cuts both ways — no catalyst to drive further aggressive selling, but also no catalyst to spark a reversal. The move is meaningful (>2%) and likely reflects real institutional flow, which statistically tends to persist intraday more often than not. No reversal pattern is evident from the data provided. Overall, slight lean toward continuation down given the magnitude and real-flow inference, but conviction is modest — probability just above the 0.5 threshold.
?Jul 29, 12:00 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.67% today with no headline catalyst visible, suggesting this is flow/momentum driven rather than news-driven. The move is meaningful but not extreme (below the 2-5% high-conviction threshold). Macro context shows 10Y inflation expectations (T10YIE) printing 1.8σ below trend, which is broadly supportive of defensively-oriented, low-duration-sensitivity sectors like healthcare distribution — MCK is a healthcare distributor and would not be particularly hurt by low inflation expectations. With 225 minutes remaining there is ample time for continuation. No reversal signals or fade patterns are evident from the data provided. No news absence penalty applies per instructions. The setup is ordinary momentum with a mildly supportive macro backdrop, warranting a modest continuation probability above 0.5 but not enough evidence for high conviction.
!Jul 29, 12:00 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.67% today with no headline catalyst visible, suggesting this is flow/momentum driven rather than news-driven. The move is meaningful but not extreme (below the 2-5% high-conviction threshold). Macro context shows 10Y inflation expectations (T10YIE) printing 1.8σ below trend, which is broadly supportive of defensively-oriented, low-duration-sensitivity sectors like healthcare distribution — MCK is a healthcare distributor and would not be particularly hurt by low inflation expectations. With 225 minutes remaining there is ample time for continuation. No reversal signals or fade patterns are evident from the data provided. No news absence penalty applies per instructions. The setup is ordinary momentum with a mildly supportive macro backdrop, warranting a modest continuation probability above 0.5 but not enough evidence for high conviction.
▣Jul 27, 8:00 PMjournaltarget
Agent 4 — Dip Buyer (Frozen) closed long 1 @ $889.86 (+$113.89)
Target hit: close $889.86 ≥ target $879.10
✓Jul 16, 10:15 AMdecisionacted
Agent 7 — Day Trader — decide: buy
MCK is up 2.83% today, a meaningful move reflecting real institutional flow. There is no MCK-specific headline driving an obvious catalyst, but absence of news is not disqualifying — large cap healthcare distributors like MCK can move on sector rotation, options activity, or earnings-related positioning. The macro context (5Y inflation breakevens 1.6σ below trend) is mildly supportive for defensive, non-cyclical names like MCK, as lower inflation expectations can compress discount rates and favor stable-cash-flow businesses. The irrelevant Cheniere headline provides no read on MCK. With 330 minutes remaining (essentially most of the trading day still ahead), there is ample time for continuation if momentum holds. The primary risks are: (1) no clear catalyst means the move could be supply-absorption rather than demand-driven, increasing fade risk; (2) a ~$22 move on a ~$800 stock is a large single-session move that may attract profit-taking into the close. Balancing the strong momentum signal against the lack of confirmed catalyst and potential for mean-reversion, a modest continuation probability is appropriate — not a high-conviction setup, but the asymmetric stop/target structure favors taking the trade.
▢Jul 15, 8:00 PMjournal
Agent 7 — Day Trader opened long 3 @ $818.92
▣Jul 15, 8:00 PMjournaltarget
Agent 7 — Day Trader closed long 3 @ $843.61 (+$74.09)
Long target: close $843.61 ≥ target $843.48
?Jul 13, 9:50 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 1.67% today, a moderate but meaningful intraday move suggesting real buying flow. There are no headlines to explain the move, but absence of news is not disqualifying — this could be sector rotation into defensive/healthcare names, which is consistent with the macro context: the T10Y2Y spread is 2.1σ below trend, indicating a flattening/near-inverted curve environment that historically benefits defensives. MCK as a large-cap healthcare distributor fits the defensive rotation thesis well. With 355 minutes remaining (essentially the full afternoon session), there is ample time for continuation. No reversal signals are evident from the data provided. The move is below the 2-5% 'high conviction' threshold, so this is an ordinary momentum read rather than a strong breakout. No macro headwinds specific to MCK's business are flagged. Assigning a modest continuation probability above the threshold — the defensive sector tailwind from the curve context provides a marginal supporting factor, but the moderate move magnitude and lack of a specific catalyst keep confidence in the ordinary range.
!Jul 13, 9:50 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 1.67% today, a moderate but meaningful intraday move suggesting real buying flow. There are no headlines to explain the move, but absence of news is not disqualifying — this could be sector rotation into defensive/healthcare names, which is consistent with the macro context: the T10Y2Y spread is 2.1σ below trend, indicating a flattening/near-inverted curve environment that historically benefits defensives. MCK as a large-cap healthcare distributor fits the defensive rotation thesis well. With 355 minutes remaining (essentially the full afternoon session), there is ample time for continuation. No reversal signals are evident from the data provided. The move is below the 2-5% 'high conviction' threshold, so this is an ordinary momentum read rather than a strong breakout. No macro headwinds specific to MCK's business are flagged. Assigning a modest continuation probability above the threshold — the defensive sector tailwind from the curve context provides a marginal supporting factor, but the moderate move magnitude and lack of a specific catalyst keep confidence in the ordinary range.
✓Jul 7, 9:45 AMdecisionacted
Agent 7 — Day Trader — decide: buy
MCK is up 6.17% intraday, a significant move representing real institutional flow. With 360 minutes remaining (effectively a full session still ahead), there is ample time for continuation. No headlines are available to explain the move, but absence of news does not disqualify momentum — large moves often precede or accompany institutional repositioning ahead of news or reflect block accumulation. The macro context (T10Y2Y at 2.1σ below trend, slightly flattening curve) is modestly relevant to defensives like MCK (healthcare/distribution), which can attract safe-haven flows in a flattening curve environment, providing a mild tailwind rather than headwind. The risk of a mean-reversion fade exists given the magnitude of the move (>6% is extended), and without a clear catalyst the setup is not high-conviction. However, the combination of strong momentum, defensive sector alignment with current macro, and ample time remaining tips the probability marginally above 0.5 for continuation. Sizing conservatively given the extended move and lack of fundamental catalyst.
▢Jul 6, 8:00 PMjournal
Agent 7 — Day Trader opened long 3 @ $802.04
▣Jul 6, 8:00 PMjournaltime_stop
Agent 7 — Day Trader closed long 3 @ $802.05 (+$0.04)
EOD forced close — day trader never carries overnight
?Jul 2, 3:11 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is up 2.16% today with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven catalyst. The macro context shows T10YIE at 1.6σ below trend, indicating compressed inflation expectations — MCK as a healthcare distributor is relatively insensitive to long-duration rate dynamics, so macro is neutral to slightly supportive (defensive positioning). With only 35 minutes remaining until the forced close, there is limited runway for further continuation; late-session momentum can persist but the time compression reduces the probability of a full extension. No reversal signal is evident (no fade mentioned), so baseline momentum bias holds. Assigning minimum continuation threshold — the move is real and uncontested by news or macro headwinds, but the short time window prevents a higher conviction read.
!Jul 2, 3:11 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MCK is up 2.16% today with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven catalyst. The macro context shows T10YIE at 1.6σ below trend, indicating compressed inflation expectations — MCK as a healthcare distributor is relatively insensitive to long-duration rate dynamics, so macro is neutral to slightly supportive (defensive positioning). With only 35 minutes remaining until the forced close, there is limited runway for further continuation; late-session momentum can persist but the time compression reduces the probability of a full extension. No reversal signal is evident (no fade mentioned), so baseline momentum bias holds. Assigning minimum continuation threshold — the move is real and uncontested by news or macro headwinds, but the short time window prevents a higher conviction read.
?Jun 23, 10:35 AMdecisionconsidered
Agent 7 — Day Trader — analyze: fail
Claude analysis failed: Anthropic 529: {"type":"error","error":{"type":"overloaded_error","message":"Overloaded"},"request_id":"req_011CcLMj6GYJ3jt8QiD3XAxG"}
!Jun 23, 10:35 AMsignal
Agent 7 — Day Trader — analyze_failed
!Jun 11, 1:46 PMsignal
options_momentum — insufficient_capital
!Jun 11, 1:33 PMsignal
options_momentum — insufficient_capital
!Jun 11, 1:17 PMsignal
options_momentum — insufficient_capital
!Jun 11, 12:46 PMsignal
options_momentum — insufficient_capital
!Jun 11, 12:33 PMsignal
options_momentum — insufficient_capital
!Jun 11, 12:17 PMsignal
options_momentum — insufficient_capital
!Jun 11, 11:47 AMsignal
options_momentum — insufficient_capital
!Jun 11, 11:34 AMsignal
options_momentum — insufficient_capital
!Jun 11, 11:19 AMsignal
options_momentum — insufficient_capital
?Jun 5, 7:01 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $3.52 cash available; close=$756.95.
?Jun 5, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
?Jun 4, 6:04 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $0.53 cash available; close=$756.95.
?Jun 4, 6:03 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
?Jun 4, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
?Jun 4, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $2.80 cash available; close=$739.53.
?Jun 3, 6:06 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
?Jun 3, 6:05 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $3.84 cash available; close=$739.95.
?Jun 3, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $2.42 cash available; close=$736.78.
?Jun 3, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
?Jun 2, 6:04 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
?Jun 2, 7:01 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $1.04 cash available; close=$734.82.
?Jun 2, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
?Jun 1, 6:04 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
?Jun 1, 6:03 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $2.27 cash available; close=$735.70.
?Jun 1, 9:30 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MCK is down ~1.92% mid-session with 375 minutes (over 6 hours) remaining, suggesting this is early in the session with ample time for the move to continue or reverse. The move is meaningful but not extreme — it represents real selling pressure but hasn't reached the 2-5% threshold that would signal strong conviction. No headlines are available to explain the catalyst, which is neutral per guidance. The macro context (T10Y3M elevated at 1.6σ above trend) is flagged as relevant to Banks and recession-sensitive sectors; MCK is a healthcare distribution company, not directly in those sectors, so macro headwinds are modest and indirect at best. With no news driver, no clear reversal pattern described, and substantial time remaining, the base case is mild momentum continuation. However, the absence of a clear catalyst and the relatively modest decline (under 2%) leave this as a low-conviction setup. Assigning a slight lean toward continuation given the meaningful selling flow and ample time remaining, but probability stays near the floor given the weak evidence base.
?Jun 1, 7:03 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $29.62 cash available; close=$742.44.
?Jun 1, 7:02 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
MCK (McKesson) is a large-cap healthcare distribution company with generally solid fundamentals; the 15% drop from the 30-day high lacks any visible fundamental catalyst (no news, no SEC filings, no insider activity in the window), suggesting the decline may be macro/sector-driven rather than company-specific impairment. However, the sector context is modestly negative (Health Care underperforming SPY by ~5.86pts over 30 days, today's sector flow proxy deeply negative), indicating MCK is caught in a broader sector-wide sell-off with limited near-term recovery catalysts. The options flow shows highly unusual put volume (z=5.58) on the most recent trading day with a near-parity P/C ratio, which is a meaningful caution signal even if some of it is hedging rather than directional bearishness.
?May 29, 6:03 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $735.32 cash available; close=$742.94.
?May 29, 7:02 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $3.04 cash available; close=$756.98.
?May 29, 7:01 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $9.19 cash available; close=$756.98.
?May 28, 6:01 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $12.25 cash available; close=$756.47.
?May 28, 6:01 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $6.30 cash available; close=$756.47.
?May 28, 7:01 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $1.29 cash available; close=$756.47.
▢May 18, 8:00 PMjournal
Agent 4 — Dip Buyer (Frozen) opened long 1 @ $775.97

← Back to dashboard